BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kumar A, Gautam V, Sandhu A, Rawat K, Sharma A, Saha L. Current and emerging therapeutic approaches for colorectal cancer: A comprehensive review. World J Gastrointest Surg 2023; 15(4): 495-519 [PMID: 37206081 DOI: 10.4240/wjgs.v15.i4.495]
URL: https://www.wjgnet.com/1948-9366/full/v15/i4/495.htm
Number Citing Articles
1
Mary Garvey. Intestinal Dysbiosis: Microbial Imbalance Impacts on Colorectal Cancer Initiation, Progression and Disease MitigationBiomedicines 2024; 12(4): 740 doi: 10.3390/biomedicines12040740
2
Purvish M Parikh, Tarini P. Sahoo, Ghanashyam Biswas, Vineet Talwar, Somashekhar SP, Soumya Surath Panda, Avinash CB, Nishita Shetty, Anita Ramesh, Joydeep Ghosh, Vijith Vital Shetty, Radheshyam Naik, Ashish Singh, Gaurav Gupta, Bhavesh Parekh. Practical Consensus Guidelines for the Use of S-1 in GI MalignanciesSouth Asian Journal of Cancer 2024; 13(01): 077 doi: 10.1055/s-0043-1778685
3
Anil Kumar, Lekha Saha. Colorectal cancer cell dormancy: An insight into pathwaysWorld Journal of Gastroenterology 2024; 30(33): 3810-3817 doi: 10.3748/wjg.v30.i33.3810
4
Alessandra Verdina, Alessia Garufi, Valerio D’Orazi, Gabriella D’Orazi. HIPK2 in Colon Cancer: A Potential Biomarker for Tumor Progression and Response to TherapiesInternational Journal of Molecular Sciences 2024; 25(14): 7678 doi: 10.3390/ijms25147678
5
Taxiarchis Konstantinos Nikolouzakis, Emmanuel Chrysos, Anca Oana Docea, Persefoni Fragkiadaki, John Souglakos, John Tsiaoussis, Aristidis Tsatsakis. Current and Future Trends of Colorectal Cancer Treatment: Exploring Advances in ImmunotherapyCancers 2024; 16(11): 1995 doi: 10.3390/cancers16111995
6
Pablo Garrido, Adrián Casas-Benito, Ignacio M. Larrayoz, Judit Narro-Íñiguez, Susana Rubio-Mediavilla, Enrique Zozaya, Alfonso Martín-Carnicero, Alfredo Martínez. Expression of Mitochondrial Long Non-Coding RNAs, MDL1 and MDL1AS, Are Good Prognostic and/or Diagnostic Biomarkers for Several Cancers, Including Colorectal CancerCancers 2024; 16(5): 960 doi: 10.3390/cancers16050960
7
Babak Arjmand, Sepideh Alavi-Moghadam, Zahra Faraji, Morteza Aghajanpoor-Pasha, Hasan Jalaeikhoo, Mohsen Rajaeinejad, Mohsen Nikandish, Ali Faridfar, Ahmad Rezazadeh-Mafi, Mostafa Rezaei-Tavirani, Arsalan Irompour. Cell Biology and Translational Medicine, Volume 22Advances in Experimental Medicine and Biology 2024; 1470: 115 doi: 10.1007/5584_2024_803
8
Soukaina Benmokhtar, Abdelilah Laraqui, Farida Hilali, Tahar Bajjou, Sara El Zaitouni, Meryem Jafari, Walid Baba, Hicham Elannaz, Idriss Amine Lahlou, Chahdi Hafsa, Mohamed Oukabli, Tarik Mahfoud, Rachid Tanz, Mohamed Ichou, Khaled Ennibi, Nadia Dakka, Yassine Sekhsokh. RAS/RAF/MAPK Pathway Mutations as Predictive Biomarkers in Middle Eastern Colorectal Cancer: A Systematic ReviewClinical Medicine Insights: Oncology 2024; 18 doi: 10.1177/11795549241255651
9
Taha I. Huda, Diep Nguyen, Arpan Sahoo, Joanna J. Song, Alexander F. Gutierrez, Boris I. Chobrutskiy, George Blanck. Adaptive Immune Receptor Distinctions Along the Colorectal Polyp-Tumor TimelapseClinical Colorectal Cancer 2024;  doi: 10.1016/j.clcc.2024.07.002
10
Barbara A Abreu Lopez, Rafael Pinto-Colmenarez, Fides Myles C Caliwag, Lorraine Ponce-Lujan, Mariela D Fermin, Ana V Granillo Cortés, Anette G Mejía Martínez, Ismael G Zepeda Martinez, Fernanda Gress León. Colorectal Cancer Screening and Management in Low- and Middle-Income Countries and High-Income Countries: A Narrative ReviewCureus 2024;  doi: 10.7759/cureus.70933
11
Maguie El Boustani, Nayla Mouawad, Monah Abou Alezz. AP3M2: A key regulator from the nervous system modulates autophagy in colorectal cancerTissue and Cell 2024; 91: 102593 doi: 10.1016/j.tice.2024.102593
12
Dawid Przystupski, Dagmara Baczyńska, Joanna Rossowska, Julita Kulbacka, Marek Ussowicz. Calcium ion delivery by microbubble-assisted sonoporation stimulates cell death in human gastrointestinal cancer cellsBiomedicine & Pharmacotherapy 2024; 179: 117339 doi: 10.1016/j.biopha.2024.117339
13
Hendra Susanto, Sa'diyatul Rizqie Amaliyah Firdaus, Moch Sholeh, Agustina Tri Endharti, Ahmad Taufiq, Nik Ahmad Nizam Nik Malek, Happy Kurnia Permatasari. Moringa oleifera Leaf Powder – Silver Nanoparticles (MOLP-AgNPs) efficiently inhibit metastasis and proliferative signaling in HT-29 human colorectal cancer cellsJournal of Agriculture and Food Research 2024; 16: 101149 doi: 10.1016/j.jafr.2024.101149
14
Anil Kumar, Bakr Ahmed, Indu Pal Kaur, Lekha Saha. Exploring dose and downregulation dynamics in lipid nanoparticles based siRNA therapy: Systematic review and meta-analysisInternational Journal of Biological Macromolecules 2024; 277: 133984 doi: 10.1016/j.ijbiomac.2024.133984
15
Otilia Menyhart, János Tibor Fekete, Balázs Győrffy. Inflammation and Colorectal Cancer: A Meta-Analysis of the Prognostic Significance of the Systemic Immune–Inflammation Index (SII) and the Systemic Inflammation Response Index (SIRI)International Journal of Molecular Sciences 2024; 25(15): 8441 doi: 10.3390/ijms25158441
16
Pengju Yao, Mingjie Gao, Weiyi Hu, Jiahao Wang, Yuhao Wang, Qingsong Wang, Jianguo Ji. Proteogenomic analysis identifies neoantigens and bacterial peptides as immunotherapy targets in colorectal cancerPharmacological Research 2024; 204: 107209 doi: 10.1016/j.phrs.2024.107209
17
Sourik Mukherjee, Dharmender Kumar, Dipanjan Guha. Insights of probiotics as an alternative medicine for cancer therapy, mechanism, and applicationsMedicine in Microecology 2024; 22: 100111 doi: 10.1016/j.medmic.2024.100111
18
Afza Ahmad, Rohit Kumar Tiwari, Saleha Siddiqui, Muskan Chadha, Ratnakar Shukla, Vivek Srivastava. Targeting Signaling Pathways in Solid Tumors - Part AInternational Review of Cell and Molecular Biology 2024; 385: 41 doi: 10.1016/bs.ircmb.2023.11.006
19
涵静 丁. Recent Advancements on the Anti-Tumor Small Molecule Inhibitors Targeting the p53-MDM2 InteractionAdvances in Clinical Medicine 2023; 13(08): 13474 doi: 10.12677/ACM.2023.1381881
20
Lena Van Dingenen, Charlotte Segers, Shari Wouters, Mohamed Mysara, Natalie Leys, Samir Kumar-Singh, Surbhi Malhotra-Kumar, Rob Van Houdt. Dissecting the role of the gut microbiome and fecal microbiota transplantation in radio- and immunotherapy treatment of colorectal cancerFrontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1298264
21
Huwei Nie, Jie Zhang, Yang Ai, Ailin Chen, Yuxi Li, Lin Zhang. Development and validation of prognostic nomograms for overall survival in patients with locally advanced colorectal cancerAlexandria Engineering Journal 2024; 87: 308 doi: 10.1016/j.aej.2023.12.040
22
Hiba Fadlallah, Jad El Masri, Hiam Fakhereddine, Joe Youssef, Chrystelle Chemaly, Samer Doughan, Wassim Abou-Kheir. Colorectal cancer: Recent advances in management and treatmentWorld Journal of Clinical Oncology 2024; 15(9): 1136-1156 doi: 10.5306/wjco.v15.i9.1136
23
Riley M. Whalen, Ashley N. Anderson, Jocelyn A. Jones, Zachary Sims, Young Hwan Chang, Michel A. Nederlof, Melissa H. Wong, Summer L. Gibbs. Ultra high content analyses of circulating and tumor associated hybrid cells reveal phenotypic heterogeneityScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-57381-8
24
Sushma S. Kumar, Ashna Fathima, Preeti Srihari, Trinath Jamma. Host-gut microbiota derived secondary metabolite mediated regulation of Wnt/β-catenin pathway: a potential therapeutic axis in IBD and CRCFrontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1392565
25
Bin Jiang, Hongjian Zhou, Xingwang Xie, Tian Xia, Chao Ke. Down-regulation of zinc finger protein 335 undermines natural killer cell function in mouse colitis-associated colorectal carcinomaHeliyon 2024; 10(4): e25721 doi: 10.1016/j.heliyon.2024.e25721
26
Luis A. Arteaga-Blanco, Andrew E. Evans, Dan A. Dixon. Plasma-Derived Extracellular Vesicles and Non-Extracellular Vesicle Components from APCMin/+ Mice Promote Pro-Tumorigenic Activities and Activate Human Colonic Fibroblasts via the NF-κB Signaling PathwayCells 2024; 13(14): 1195 doi: 10.3390/cells13141195
27
Yiping Zhang, Jun Xie. Targeting ferroptosis regulators by natural products in colorectal cancerFrontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1374722
28
Sara Assi, Berthe Hayar, Claudio Pisano, Nadine Darwiche, Walid Saad. Novel ST1926 Nanoparticle Drug Formulation Enhances Drug Therapeutic Efficiency in Colorectal Cancer Xenografted MiceNanomaterials 2024; 14(17): 1380 doi: 10.3390/nano14171380
29
Samuele Tardito, Serena Matis, Maria Raffaella Zocchi, Roberto Benelli, Alessandro Poggi. Epidermal Growth Factor Receptor Targeting in Colorectal Carcinoma: Antibodies and Patient-Derived Organoids as a Smart Model to Study Therapy ResistanceInternational Journal of Molecular Sciences 2024; 25(13): 7131 doi: 10.3390/ijms25137131
30
Marcel Madej, Celina Kruszniewska-Rajs, Magdalena Kimsa-Dudek, Agnieszka Synowiec-Wojtarowicz, Elwira Chrobak, Ewa Bębenek, Stanisław Boryczka, Stanisław Głuszek, Jolanta Adamska, Sebastian Kubica, Jarosław Matykiewicz, Joanna Magdalena Gola. The Influence of Betulin and Its Derivatives on Selected Colorectal Cancer Cell Lines’ Viability and Their Antioxidant SystemsCells 2024; 13(16): 1368 doi: 10.3390/cells13161368
31
Francesco Gervasi, Fanny Pojero. Use of Oleuropein and Hydroxytyrosol for Cancer Prevention and Treatment: Considerations about How Bioavailability and Metabolism Impact Their Adoption in Clinical RoutineBiomedicines 2024; 12(3): 502 doi: 10.3390/biomedicines12030502
32
Nikola Radenković, Danijela Nikodijević, Jovana Jovankić, Stefan Blagojević, Milena Milutinović. Resistance to 5-fluorouracil: The molecular mechanisms of development in colon cancer cellsEuropean Journal of Pharmacology 2024; 983: 176979 doi: 10.1016/j.ejphar.2024.176979
33
Marcel Madej, Joanna Gola, Elwira Chrobak. Synthesis, Pharmacological Properties, and Potential Molecular Mechanisms of Antitumor Activity of Betulin and Its Derivatives in Gastrointestinal CancersPharmaceutics 2023; 15(12): 2768 doi: 10.3390/pharmaceutics15122768
34
Duogang Xu, Yulei He, Changkang Liao, Jing Tan. Combining KRAS gene status with preoperative D‑dimer levels as a predictive marker of venous thromboembolism risk in patients with resectable colorectal cancer: A prospective cohort studyBiomedical Reports 2024; 20(6) doi: 10.3892/br.2024.1784
35
Sayan Saha, Shreya Ghosh, Suman Ghosh, Sumit Nandi, Aditi Nayak. Unraveling the complexities of colorectal cancer and its promising therapies – An updated reviewInternational Immunopharmacology 2024; 143: 113325 doi: 10.1016/j.intimp.2024.113325
36
Shiliang Cheng, Meng Li, Chunguang Li, Yonggang Dai, Jinhua Zhuo, Jue Wang, Jingrong Qian, Zhihao Hao. JAML inhibits colorectal carcinogenesis by modulating the tumor immune microenvironmentIn Vitro Cellular & Developmental Biology - Animal 2024; 60(4): 382 doi: 10.1007/s11626-024-00881-8
37
Maxim Girod, Anja Geisler, Luisa Hinze, Leslie Elsner, Babette Dieringer, Antje Beling, Jens Kurreck, Henry Fechner. Combination of FOLFOXIRI Drugs with Oncolytic Coxsackie B3 Virus PD-H Synergistically Induces Oncolysis in the Refractory Colorectal Cancer Cell Line Colo320International Journal of Molecular Sciences 2024; 25(11): 5618 doi: 10.3390/ijms25115618
38
Irene Palenca, Silvia Basili Franzin, Aurora Zilli, Luisa Seguella, Anna Troiani, Federico Pepi, Martina Vincenzi, Giuseppe Giugliano, Viviana Catapano, Italia Di Filippo, Giovanni Sarnelli, Giuseppe Esposito. N‐palmitoyl‐d‐glucosamine limits mucosal damage and VEGF‐mediated angiogenesis by PPARα‐dependent suppression of pAkt/mTOR/HIF1α pathway and increase in PEA levels in AOM/DSS colorectal carcinoma in micePhytotherapy Research 2024;  doi: 10.1002/ptr.8303
39
Ashok Kumar, Anirudh Goyal. Emerging molecules, tools, technology, and future of surgical knife in gastroenterologyWorld Journal of Gastrointestinal Surgery 2024; 16(4): 988-998 doi: 10.4240/wjgs.v16.i4.988
40
Chiugo Okoye, My Tran, Elizabeth Soladoye, Darlington E Akahara, Chinemerem M Emeasoba, Blessing T Ojinna, Emmanuel Anasonye, Oyindamola O Obadare, Chiamaka S Diala, Bolanle H Salaudeen, Endurance O Evbayekha, Okelue E Okobi. A Review of 10-Year Survivability of Immunotherapy in the Management of Colon CancerCureus 2023;  doi: 10.7759/cureus.43189
41
Sezgin Zeren, Semih Seker, Gizem Akkaş Akgün, Emrah Okur, Azmi Yerlikaya. Label-free nLC-MS/MS proteomic analysis reveals significant differences in the proteome between colorectal cancer tissues and normal colon mucosaMedical Oncology 2023; 40(10) doi: 10.1007/s12032-023-02173-9
42
Raza M. Mirza, Sabrin Salim, Jennifer A. H. Bell, Mary Jane Esplen, Karen V. MacDonald, Barry D. Stein, Deborah A. Marshall. Exploring How Values of Colorectal Cancer Patients and their Caregivers Influence Treatment Decision-MakingThe Patient - Patient-Centered Outcomes Research 2024;  doi: 10.1007/s40271-024-00716-4
43
Jae Yeon Choi, Hyun Jeong Seok, Dong Hyeon Lee, Junhye Kwon, Ui Sup Shin, Incheol Shin, In Hwa Bae. miR-1226-5p is involved in radioresistance of colorectal cancer by activating M2 macrophages through suppressing IRF1Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05797-1
44
Claudia C. Wahoski, Bhuminder Singh. The Roles of RAC1 and RAC1B in Colorectal Cancer and Their Potential Contribution to Cetuximab ResistanceCancers 2024; 16(13): 2472 doi: 10.3390/cancers16132472
45
Mariana Melo Moreira, Marta Carriço, Manuel Luís Capelas, Nuno Pimenta, Teresa Santos, Susana Ganhão-Arranhado, Antti Mäkitie, Paula Ravasco. The impact of pre-, pro- and synbiotics supplementation in colorectal cancer treatment: a systematic reviewFrontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1395966